Answers are grounded in this paper and cite their sources.
Aims and background:This study aims to evaluate indirect immunofluorescence assay (IFA) and immunoblot (IBM) methods for antinuclear antibody (ANA) detection in Pakistani patients and to investigate the correlation between autoimmune diseases and different autoantibodies.Materials and methods: A total of 1,070 patients of all ages and both sexes who visited Liaquat National Hospital and Medical College from January 2018 to December 2018 for ANA testing were included in this retrospective study.These patients were referred by the physicians at the Rheumatology Clinic, Liaquat National Hospital, Karachi, for the detection of antinuclear antibodies.Antinuclear antibodies (ANA) were screened using the IFA Mosaic Basic Profile Kit (Euroimmun), while ANA-specific antibodies were further pinpointed using the ANA profile 3 immunoblot kit (Euroimmun).Results: Out of 1,070 patients, 316 were males (29.5%) and 754 (70.4%) were females.Among these 254 (23.7%) cases were found positive by ANA IFA and 262 (24.5%) by ANA IBM.In contrast, 816 cases (76.2%) were found negative by ANA IFA, and 808 cases (75.5%) were negative by ANA IBM.There was a 96% total coincidence rate for both ANA IFA and ANA IBM, whereas there were 90.4% positive and 97.8% negative coincidences. Conclusion:Overall, this study shows a moderate prevalence of autoimmune disease and autoantibodies in Pakistani patients, with a higher frequency in females.Although ANA IFA is considered the gold standard for figuring out autoimmune diseases, and ANA IBM further confirms the type of antibodies present in patients' sera, the combination of these two methods can serve as a more effective way to detect autoimmune diseases.
No takes yet. Share an insight, caveat, or question.
Perveen et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: